Efficacy and safety of apatinib plus docetaxel for non-squamous non-small cell lung cancer with bone metastases.

被引:0
作者
Zang, Aimin
Sun, Guoguo
机构
[1] Hebei Med Univ, Affiliate Hosp, Baoding, Peoples R China
[2] Tangshan Peoples Hosp, Tangshan, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e21741
引用
收藏
页数:1
相关论文
共 50 条
[41]   Efficacy and safety of sintilimab plus docetaxel in patients with previously treated advanced non-small cell lung cancer (NSCLC) [J].
Wang, Z. ;
Han, X. ;
Guo, J. ;
Zhu, D. ;
Zhang, X. ;
Tang, X. ;
Meng, X. .
ANNALS OF ONCOLOGY, 2020, 31 :S1400-S1400
[42]   Activity and safety of pembrolizumab in patients with metastatic non-small cell lung cancer with untreated brain metastases. [J].
Goldberg, Sarah B. ;
Gettinger, Scott N. ;
Mahajan, Amit ;
Herbst, Roy S. ;
Chiang, Anne C. ;
Tsiouris, A. John ;
Vortmeyer, Alexander ;
Jilaveanu, Lucia ;
Speaker, Stephanie ;
Madura, Matthew ;
Rowen, Elin ;
Gerrish, Heather ;
Knapp-Perry, Elizabeth ;
Yao, Xiaopan ;
Chiang, Veronica ;
Kluger, Harriet M. .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[43]   Safety of nintedanib plus docetaxel in advanced non-squamous NSCLC (nsNSCLC) patients: The preliminary results of the SENECA (second-line nintedanib in non-small cell lung cancer) trial [J].
Morelli, A. M. ;
Migliorino, M. R. ;
Morabito, A. ;
Chiari, R. ;
Grossi, F. ;
Bordi, P. ;
Di Costanzo, F. ;
Delmonte, A. ;
Romano, G. ;
Misino, A. ;
Scotti, V. ;
Gregorc, V. ;
Pisconti, S. ;
Ceresoli, G. L. ;
Del Conte, A. ;
Colantonio, I. ;
Ciuffreda, L. ;
Capelletto, E. ;
Stura, I. ;
Novello, S. .
ANNALS OF ONCOLOGY, 2018, 29
[44]   Predictors of skeletal-related events in non-small cell lung cancer patients with bone metastases. [J].
Sun, J. ;
Ahn, J. ;
Lee, J. ;
Park, Y. ;
Lee, S. ;
Ahn, M. ;
Park, K. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[45]   Docetaxel and non-small cell lung cancer [J].
Le Guen, Y ;
Le Cesne, A .
BULLETIN DU CANCER, 2004, 91 (03) :263-270
[46]   Phase II Study of Docetaxel-plus-Bevacizumab Combination Therapy in Patients Previously Treated for Advanced Non-squamous Non-small Cell Lung Cancer [J].
Ohyanagi, Fumiyoshi ;
Yanagitani, Noriko ;
Kudo, Keita ;
Kawano, Yuko ;
Sakatani, Toshio ;
Tanimoto, Azusa ;
Nishizawa, Hironari ;
Horiike, Atsushi ;
Hagiwara, Sachiko ;
Horai, Takeshi ;
Nishio, Makoto .
ANTICANCER RESEARCH, 2014, 34 (09) :5153-5158
[47]   Efficacy and safety of maintenance immune checkpoint inhibitors with or without pemetrexed in advanced non-squamous non-small cell lung cancer: a retrospective study [J].
Xiaodong Gu ;
Zhiyong Shi ;
Lan Shao ;
Yuxin Zhang ;
Yiping Zhang ;
Zhengbo Song ;
Wenxian Wang ;
Guangyuan Lou .
BMC Cancer, 22
[48]   Efficacy and safety of apatinib monotherapy in elderly patients with advanced metastatic non-small cell lung cancer [J].
Li, Jian ;
Tong, Xiwen ;
Li, Hongtao .
INDIAN JOURNAL OF CANCER, 2020, 57 (01) :13-17
[49]   Efficacy and safety of maintenance immune checkpoint inhibitors with or without pemetrexed in advanced non-squamous non-small cell lung cancer: a retrospective study [J].
Gu, Xiaodong ;
Shi, Zhiyong ;
Shao, Lan ;
Zhang, Yuxin ;
Zhang, Yiping ;
Song, Zhengbo ;
Wang, Wenxian ;
Lou, Guangyuan .
BMC CANCER, 2022, 22 (01)
[50]   THE EFFICACY AND TOXICITY OF CHEMOTHERAPY WITH BEVACIZUMAB FOR PREVIOUSLY TREATED PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER [J].
Itotani, R. ;
Kitajima, T. ;
Inoue, D. ;
Takamatsu, K. ;
Ishitoko, M. ;
Marumo, S. ;
Sakuramoto, M. ;
Fukui, M. .
JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (04) :S47-S47